Exercise as an end‐point in pulmonary hypertension trials
暂无分享,去创建一个
[1] C. Strange,et al. Limitations to the 6-Minute Walk Test in Interstitial Lung Disease and Pulmonary Hypertension in Scleroderma , 2009, The Journal of Rheumatology.
[2] Himanshu Gupta,et al. Role of cardiac magnetic resonance imaging in the management of patients with pulmonary arterial hypertension. , 2008, Journal of the American College of Cardiology.
[3] R. Naeije,et al. Pulmonary hypertension in COPD , 2008, European Respiratory Journal.
[4] P. Postmus,et al. Exercise testing to estimate survival in pulmonary hypertension. , 2008, Medicine and science in sports and exercise.
[5] J. Seibold,et al. The 6-minute walk test in scleroderma--how measuring everything measures nothing. , 2008, Rheumatology.
[6] M. Tamm,et al. A randomised, controlled trial of bosentan in severe COPD , 2008, European Respiratory Journal.
[7] M. Humbert,et al. Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension , 2008, European Respiratory Journal.
[8] B. Kjellström,et al. Continuous hemodynamic monitoring in patients with pulmonary arterial hypertension. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[9] C. Tei,et al. Repeated waon therapy improves pulmonary hypertension during exercise in patients with severe chronic obstructive pulmonary disease. , 2008, Journal of cardiology.
[10] R. Neviere,et al. Cardiac Correlates of Exercise Induced Pulmonary Hypertension in Patients with Chronic Heart Failure Due to Left Ventricular Systolic Dysfunction , 2008, Echocardiography.
[11] N. Westerhof,et al. Sildenafil treatment in COPD does not affect stroke volume or exercise capacity , 2008, European Respiratory Journal.
[12] D. Webb,et al. Phosphodiesterase type 5 inhibition reverses impaired forearm exercise-induced vasodilatation in hypertensive patients , 2008, Journal of hypertension.
[13] D. Huo,et al. Creation of a model comparing 6-minute walk test to metabolic equivalent in evaluating treatment effects in pulmonary arterial hypertension. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[14] T. Abraham,et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. , 2006, American journal of respiratory and critical care medicine.
[15] D. Mccrory,et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. , 2004, Chest.
[16] Gilles Garcia,et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. , 2002, Journal of the American College of Cardiology.
[17] R. Hetzer,et al. Assessment of Survival in Patients With Primary Pulmonary Hypertension: Importance of Cardiopulmonary Exercise Testing , 2002, Circulation.
[18] M. Rubenfire,et al. Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension. , 2001, The European respiratory journal.
[19] M. Fujita,et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. , 2000, American journal of respiratory and critical care medicine.
[20] J B Seward,et al. Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension. , 1998, The American journal of cardiology.
[21] D. Dresdale,et al. Primary pulmonary hypertension. I. Clinical and hemodynamic study. , 1951, The American journal of medicine.
[22] R. Ara,et al. The direct healthcare costs associated with ankylosing spondylitis patients attending a UK secondary care rheumatology unit. , 2008, Rheumatology.
[23] J. E. Hansen,et al. Cardiopulmonary exercise testing and six-minute walk correlations in pulmonary arterial hypertension. , 2006, The American journal of cardiology.
[24] M. Mcgregor,et al. On pulmonary vascular resistance: the need for more precise definition. , 1985, The American journal of cardiology.